Melphalan 50 mg powder and solvent for solution for injection/infusion

DRUG2 trials

Sponsors

Fondazione Gimema Franco Mandelli Onlus, St. Anna Childrens Cancer Research Institute GmbH

Conditions

Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.Langerhans Cell Histiocytosis

Phase 2

LCH-IV International Collaborative Treatment Protocol for Children and Adolescents with Langerhans Cell Histiocytosis

Not yet recruitingCTIS2024-512676-36-00

St. Anna Childrens Cancer Research Institute GmbHLangerhans Cell Histiocytosis

Target: 1124Updated: 2024-10-14

Phase 3

Newly Diagnosed Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL). Sequential Treatment with Ponatinib and the Bispecific Monoclonal Antibody Blinatumomab vs Chemotherapy and Imatinib. ALL2820

Active, not recruitingCTIS2023-508968-30-00

Fondazione Gimema Franco Mandelli OnlusAdult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.

Start: 2021-09-08Target: 236Updated: 2024-10-01